Effect of Virtual Reality on Prostaglandin Levels in Adolescent Females With Primary Dysmenorrhea

Effect of Virtual Reality on Prostaglandin Levels in Adolescent Females With Primary Dysmenorrhea: A Randomized Controlled Trial

This study will be conducted to study the effect of virtual reality therapy on prostaglandin levels in adolescent females with primary dysmenorrhea.

Primary dysmenorrhea is thought to be caused by excessive levels of prostaglandins, which are hormones that stimulate the uterus to contract during menstruation and childbirth, Treatment must be tailored to individual patient symptoms. Pharmacologic management with non-steroidal anti-inflammatory medications and/or combined hormonal contraceptives is most common. Heat therapy, exercise, vitamins and dietary supplements have limited evidence and can be offered for patients seeking non-pharmacologic adjunctive or alternative options. Greater awareness for both health-care providers and patients allow for early intervention to reduce impact on quality of life and life course potential. The significance of this study to assess the effect of virtual reality therapy on primary dysmenorrhea.

Inclusion Criteria:

• Age 17- 21 years old.
• The body mass index (BMI) < 30 kg/m2.
• Unmarried females.
• Females with dysmenorrhea pain.
• Females with regular menstrual cycles.
• Females with normal gynecology.

Exclusion Criteria:

• Have a pathological disease related to reproduction.
• Students who use analgesic drugs for 3 months/3 menstrual cycles.
• Students with menstrual pain secondary to diagnosed organic or inflammatory causes.